The most controversial and pending bills like abortion and cloning were heard by the House State Affairs Committee in presence of overcrowded supporters and opponents of the bills.
Stem cell research in the UK has taken a new turn. Just after the hybrid human cloning get approval in the country, a leading British scientist decided to go France to conduct research because he finds the nation too focused on embryonic stem cell research.
Latest news reveals about the declination of amendments of abortion and the passage of new bill which includes the permission to research on different embryos for finding cure to different non-curable diseases.
British scientists Ian Wilmut and Keith Campbell have received the Shaw Prize, the million-dollar award known as the Nobel Prize of the east for their contribution to the world of stem cell. Both of them are known to be the creator of Dolly.
The father of the stem cell research and the creator of the sheep Dolly, Ian Wilmut, has decided to step out of the stem cell research and to jump to the alternative medicine. Way back in 1997, when he and his co researchers have created the cloned sheep, the stem cell had entered a new horizon. “Dolly was a big surprise to everyone,” recalls stem cell biologist Thomas Zwaka of the Center for Cell and Gene Therapy at the Baylor College of Medicine. With the changing time, the technology that created Dolly, is to be called as a separate research theory called the somatic cell nuclear transfer (SCNT). The technology places the nucleus into an unfertilized human egg and then harvest embryonic stem cells to treat intractable conditions such as Parkinson’s disease.
The stem cell research is likely to enter a new stage when the Stemagen Corporation, based in La Jolla, California, claims that it used cloning technology to make five human embryos. This means that hope is on the horizon that they will be able to make matched stem cells for patients.
Hwang’s Sooam Biotech Research Foundation in South Korea and Bio Arts International (animal and human genomic industry) are going to start a dog breeding business in partnership. Bio Arts announced that they are going to start an auction from June 18th, where dog owners can bid a minimum of $100,000 for the right to have their dogs cloned.